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ABSTRACT
Introduction As of 2015, as part of the implementation 
of the Welsh Government primary care plan and primary 
care clusters, the Welsh Government has encouraged non- 
medical healthcare professionals working in primary care 
to train as independent prescribers (IPs).
Objectives This research aimed to identify the number 
of NMIPs in primary care in Wales and describe their 
prescribing trend of items between 2011 and 2018, in 
order to compare their prescribing pattern before and after 
the implementation of primary care clusters for Wales.
Design Retrospective secondary data analysis and 
interrupted time series analysis in order to compare 
prescribing by non- medical independent prescribers 
(NMIPs) preimplementation and postimplementation of 
primary care clusters across Wales.
Results Over the study period, 600 NMIPs (nurses 
n=474 and pharmacists n=104) had prescribed at least 
one item. The number of nurse IPs increased by 108% 
and pharmacists by 325% (pharmacists had the largest 
increase between July 2015 and March 2018). The 
number of items prescribed by NMIPs increased over 
time by an average of 1380 per month (95% CI 904 to 
1855, p<0.001) after the implementation of primary care 
clusters compared with 496 (95% CI 445 to 548, p<0.001) 
prior its implementation. Approximately one- third of the 
items prescribed by NMIPs was within Betsi Cadwaladr 
University Health Board (HB) with only 4% in Powys 
Teaching HB.
Conclusion The number of NMIPs and their volume 
of prescribing in primary care in Wales has increased 
following the implementation of primary care clusters 
in 2015. This suggests that the Government’s 
recommendations of using NMIPs in primary care have 
been implemented. Future studies should focus on 
efficiency and quality of prescribing by NMIPs in primary 
care.
INTRODUCTION
The right to prescribe medicines was tradi-
tionally restricted to physicians, dentists and 
veterinary surgeons.1 Prescribing practice has 
changed over the last 50 years to involve physi-
cians and dentists (medical prescribers) and 
other healthcare professionals, known as non- 
medical prescribers. The adoption of non- 
medical prescribing fundamentally began in 
the USA in the 1960s2 and has extended to 
the UK, Canada, New Zealand, Australia and 
other European and African nations.3 Beyond 
the UK, solely nurses and pharmacists have 
been granted the authority to prescribe medi-
cines collaboratively (dependently) under 
a physician’s supervision or independently 
from a limited lists of medicines.4–7 The drive 
Strengths and limitations of this study
 ► This is the first study using a secondary database 
analysis, which has provided insights and empirical 
findings on the prescribing pattern of medicines by 
non- medical independent prescribers (NMIPs) over 
time in primary care in Wales.
 ► The data provided via the Comparative Analysis 
System for Prescribing Audit (CASPA) software sys-
tem was limited to the last 7 years and only captured 
prescriptions that were dispensed in community 
pharmacies.
 ► The CASPA system was designed for financial re-
imbursement purposes for community pharmacies, 
which means that holding investigations at the lev-
el of patients or prescribers, such as stopping or 
changing patients’ medications, as well as clinical 
safety issues or other prescribing activities, were not 
possible.
 ► The professions of NMIPs as pharmacist, nurse, 
physiotherapist or others were not identified on 
the prescriptions and, consequently, in the CASPA 
system.
 ► The interrupted time series analysis has the strength 
of evaluating data at the whole population level, 
which allowed the researchers to evaluate the utili-
sation of NMIPs in primary care across all of Wales.
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to extend the medicines prescribing mandate to non- 
medical healthcare professionals was related to a variety 
of aspects within every nation.
In the UK, non- medical prescribing was introduced 
as part of the National Health Service (NHS) plans, 
which intended to improve and modernise the health-
care system.8 9 The aim of introducing non- medical 
prescribing was to enhance patient care and safety, 
improve patient access and choice of appropriate medi-
cines for their conditions, use the already gained skills 
of healthcare professionals in the most effective way 
and promote a more flexible teamwork environment 
in the NHS.10 Pharmacists, nurses, optometrists and 
allied health professionals can qualify as non- medical 
prescribers after completing an advanced prescribing 
training programme.9 10 This programme lawfully allows 
these healthcare professionals to prescribe within their 
area of competence, such as that pharmacists and nurses 
can prescribe medicines, appliances and wound dress-
ings as either independent or supplementary prescribers 
within their clinical area of practice. Some non- medical 
independent prescriber (NMIPs) are limited to prescribe 
certain medications within their clinical of specialty, such 
as optometrists who can only prescribe for eye conditions 
and surrounding tissues.9
Independent prescribing is defined as ‘prescribing by a 
practitioner (eg, a doctor, dentist, nurse, or a pharmacist) 
responsible and accountable for the assessment of patients 
with undiagnosed or diagnosed conditions and for deci-
sions about the clinical management required, including 
prescribing’.10 Whereas, supplementary prescribing is a 
‘voluntary partnership between the responsible indepen-
dent prescriber (IP) and a supplementary prescriber, to 
implement an agreed patient- specific clinical manage-
ment plan with the patient’s agreement, particularly but 
not only in relation to prescribing for a specific non- acute 
medical condition or health need affecting the patient’.11 
Non- medical independent prescribing was introduced in 
the UK in 2002 after a change in the legislation made 
by the UK Government allowing the first level registered 
nurses who have at least 3 years of experience to prescribe 
independently from a limited list of medicines.10 12 In 
2006, independent prescribing extended for qualified 
nurses and pharmacists who completed the necessary 
training to prescribe any medicines within their area of 
competence with few exceptions.10 This was followed by 
the introduction of optometrist independent prescribing 
in 200713 and, more recently, independent prescribing 
by allied health professionals including podiatrists and 
physiotherapists independent prescribing in 201314 and 
therapeutic radiographers independent prescribing in 
2016.15 The recent healthcare professionals who gained 
the prescribing authority in Wales were paramedics in 
2019. In 2017, the estimated number of NMIPs in the 
UK was as follows: 30 000 nurse IPs; 3000 pharmacist IPs 
and 600 allied health professionals IPs.16 All NMIPs are 
responsible and accountable for their own prescribing 
and limiting their prescribing to their therapeutic area 
of expertise.9 Moreover, these healthcare professionals 
are required to seek appropriate advice or referral if they 
lack the confidence to manage patients’ conditions or 
prescribe the suitable medicines for their patients.9
In Wales, the NHS provides its services via three NHS 
Trusts and seven health boards (HBs). The seven HBs 
are Swansea Bay University HB (SBUHB), Cardiff and 
Vale University HB, Cwm Taf Morgannwg University HB, 
Hywel Dda University HB (HDUHB), Powys Teaching HB 
(PTHB), Betsi Cadwaladr University HB (BCUHB) and 
Aneurin Bevan University HB (ABUHB). The SBUHB 
was formerly known as Abertawe Bro Morgannwg Univer-
sity HB (ABMUHB), having being renamed in 2019.
Primary healthcare services are the initial point of 
care for patients in the NHS. In Wales, it has been esti-
mated that around 90% of people’s contact with the NHS 
is with primary care services, with general practices the 
main point of contact.17 In 2016, there were 441 general 
practices in Wales and 2009 general practitioners (GPs) 
(excluding, locums, retainers and registrars).18 The 
Welsh Government and HBs have focused on improving 
primary care services,17 and this has included the develop-
ment of primary care clusters. Clusters comprise groups 
of adjacent general practices that have linked together 
to provide advanced medical services locally in order to 
relieve pressure on hospitals.19 The aims of these clusters 
include improving patients’ access to their medicines 
and information as well as the provision of advice and 
support to manage medicines. These clusters came into 
being in the last quarter of 2015.19 Currently, there are 
64 primary care clusters in Wales that provide services 
for a population of 30 000 to 50 000 patients per cluster.19 
In order to overcome GP shortages,20 21 these clusters 
are supported by high numbers of hospital pharmacists, 
nurses and other professionals. In addition, the Welsh 
Government and HBs have prioritised funding for new 
posts and training of other healthcare professionals, such 
as pharmacist and nurse IPs.17 Consequently, the number 
of non- medical prescribers in primary care has increased 
in recent years and is expected to rise further.16 21
Only one published study has investigated the imple-
mentation of non- medical prescribing in Wales.16 This 
study aimed to provide an overview of the implementation 
and utilisation of non- medical prescribing in all health-
care sectors through a national questionnaire survey. The 
results of this study indicated that the majority of non- 
medical prescribers in Wales were based in secondary 
care settings. Moreover, these researchers stated that 
the utilisation of non- medical prescribers across Wales, 
particularly in primary care, was inconsistent and had 
not been implemented in all services. In addition, it was 
suggested that there was a need to investigate and recog-
nise the development of primary care services in Wales, 
with support required for non- medical prescribers.16
The aim of this study was to identify the number of 
NMIPs in Wales and describe their prescribing volume 
(from April 2011 to March 2018) as a whole, as well as 
within the seven HBs, before and after the implementation 
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of primary care clusters. This is the first study in Wales to 
use data obtained through a national database to review 
prescribing volume by NMIPs in primary care. No equiva-
lent studies have been published internationally.
METHODOLOGY
The study design was a retrospective secondary data anal-
ysis of monthly data for prescriptions issued by NMIPs in 
primary care in Wales and dispensed in community phar-
macies, as well as the data on the number of NMIPs within 
primary care in Wales.
The number of NMIPs who prescribed each month 
and who prescribed at least one item from April 2011 to 
March 2018 was obtained through the NHS Wales Shared 
Services Partnership, Primary Care Services. Prescribing 
data were obtained from the Comparative Analysis System 
for Prescribing Audit (CASPA) software system (V.5), 
provided by the NHS Wales Shared Services. Data were 
fully anonymised and recorded as part of routine prac-
tice; as such, the study did not require ethical approval. 
CASPA records all dispensed WP10 prescriptions (NHS 
Welsh prescriptions for use in primary care), to allow 
financial reimbursement to community pharmacies.9 
While it is acknowledged that dispensing may not fully 
reflect prescribing, due to patients not taking their 
prescriptions to a pharmacy for dispensing, the impact 
of this is likely to be small. This is due to the prescrip-
tion charge for people in Wales was abolished in 2007 
allowing all patients who were registered with their Welsh 
GPs to get their prescriptions dispensed from a phar-
macy in Wales free of charge.22 As a result, the impact 
of non- dispensed items would have been reduced by this 
policy, which also limits the financial burden to patients. 
Therefore, dispensing was used as a surrogate marker for 
prescribing in this study.
The number of items refers to each single item 
prescribed by a prescriber on a prescription form to a 
patient.23 All recorded WP10 prescriptions issued by GPs 
and NMIPs in Wales and dispensed by community phar-
macists from April 2011 to March 2018 were extracted and 
included in the study. The number of prescribed items 
by NMIPs were extracted from the CASPA system on a 
monthly basis, and the total number of items per 100 000 
population (the population data in Wales as a whole and 
in each HB obtained from the Welsh Government Stats 
Wales24) was calculated in order to take the population 
into consideration. Percentages were calculated for the 
total number of prescribed items by NMIPs in each HB. 
The name of ABMUHB was used to illustrate the findings 
in this HB as this was its name over the study period.
Although randomised controlled trials are considered 
the gold standard method to evaluate longitudinal effects 
of interventions over time,25–27 they lack the ability to eval-
uate the already implemented service retrospectively.27 
Therefore, prescribing trend data were compared before 
and after the introduction of primary care clusters (the 
intervention) by using an interrupted time series (ITS) 
analysis. This analysis was performed using ordinary- 
least squares regression with Newey- West SEs and a lag 
for the autocorrelation structure. The Cumby- Huizinga 
test for autocorrelation was examined to determine the 
appropriate autocorrelation structure to be accounted 
for in the model. The model included preintervention 
and postintervention trends, as well as a coefficient to 
examine a change in level immediately postintervention. 
The parameter estimates are presented alongside 95% 
CIs and p values. The counterfactual trend (ie, the trend 
in the absence of the intervention) was examined, and 
this was compared with the actual observed trend to calcu-
late absolute and relative differences at the end of the 
observed period (March 2018). Analysis was performed 
using the itsa command in Stata V.16.0.28 The findings 
were assumed significant at p value <0.05. CIs were calcu-
lated in order to be 95% certain that the range of values 
contained the true mean of the data.29
The Welsh Government plan17 encouraged local HBs 
to prioritise funding and development of primary care 
clusters in April 2015. However, the implementation of 
these clusters is the responsibility of each individual local 
HB, and there are no definitive time points of their estab-
lishment. To accommodate this, the researchers engaged 
with the relevant stakeholders (eg, policy makers and 
chief pharmaceutical officer) to determine the appro-
priate time for the intervention phase. They agreed the 
intervention phase began 6 months after the provided 
funding by the government to HBs, meaning October 
2015, to allow for an appropriate time for each HB to 
train NMIPs.
Patient and public involvement
This research was done without patient and public involve-
ment. Patients were not invited to comment on the study 
design and were not consulted to develop patient rele-
vant outcomes or interpret the results. Patients were not 
invited to contribute to the writing or editing of this docu-
ment for readability or accuracy.
RESULTS
Trend of the total number of items prescribed by all 
prescribers
The total number of items prescribed by all health-
care professionals (GPs and non- medical prescribers) 
from April 2011 to March 2018 was 540 781 584 items 
(17 482 150 per 100 000 population). The total number 
of prescribed items per 100 000 population per year 
increased by 7.1% between 2011 and 2012 (n=2 371 511) 
and 2014–2015 (n=2 539 192) and increased by 0.7% 
between 2014 and 2015 (n=2 539 192) and 2017–2018 
(n=2 556 784) (figure 1).
Trend of the total number of items prescribed by NMIPs
The total number of items prescribed by NMIPs in 
primary care in Wales between April 2011 and March 2018 
was 5 088 405 items (n=1 64 130 per 100 000 population). 
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The number of items prescribed as a percentage of all 
items prescribed by all healthcare professionals (except 
items prescribed by dentists) increased from 0.57% in 
2011–2012 to 1.7% in 2017–2018. As shown in table 1 and 
figure 2, dispensed prescriptions by NMIPs in primary 
care started at 31 756 and increased on average per month 
prior to the implementation of primary care clusters by 
496 (95% CI 445 to 548, p<0.001). There was no evidence 
to suggest a change in the level immediately following the 
implementation of primary care clusters in October 2015. 
However, following this implementation, there was an 
increase in dispensed prescriptions per month, relative to 
preimplementation trends, of 1380 on average (95% CI 
904 to 1855, p<0.001).
Assuming the preimplementation trend would have 
continued in the absence of the introduction of primary 
care clusters, the expected number of dispensed 
prescriptions by NMIPs at the end of the observation 
period (March 2018) was 73 443 (95% CI 70 260 to 
76 627), and with the model predicting an expected 
number (in the presence of primary care clusters) of 
117 859 (95% CI 108 049 to 1 27 670), there was a 60% 
relative increase in the number of dispensed prescrip-
tions by NMIPs following the implementation of 
primary care clusters over and above what would have 
been expected in the absence of such a scheme (95% CI 
46 to 75, p<0.001).
The total number of NMIPs
Data obtained from the NHS Wales Shared Services 
Partnership shows that the total number of NMIPs who 
prescribed at least one item from April 2011 to March 
2018 was 600 prescribers (474 nurses, 104 pharmacists, 
21 physiotherapists and 1 with unknown profession). 
The total number of NMIPs in each HB is illustrated in 
figure 3. The number of prescribing NMIPs per month 
increased by approximately 140% between April 2011 
(n=174) and March 2018 (n=414). Of those, the number 
of nurses increased from 158 in April 2011 to 328 in 
March 2018 (an increase of 108%). The number of phar-
macists increased from 16 in April 2011 to 68 in March 
2018 (an increase of 325%), the largest increase was 
from July 2015 (n=20) to March 2018 (n=68) by 240%. 
In January 2015, the first physiotherapist IP started to 
prescribe with the number increasing to 17 in March 
2018.
Trend of the total number of prescribed items by NMIPs in 
different HBs preintervention and postintervention
Table 2 presents the total number of items prescribed 
by NMIPs, as well as the number per 100 000 population 
and percentage of all items prescribed, per HB. Approx-
imately one- third of the items prescribed by NMIPs was 
within BCUHB (table 2) with only 4% in PTHB. Data by 
HBs are illustrated in figures 4 and 5, and it can also be 
seen in the online supplemental file.
Table 1 Parameter estimates from the interrupted time 
series analysis examining the change in level and slope of 
dispensed prescriptions in primary care by NMIPs following 
the implementation of primary care clusters in October 2015 
(n=84 months)
Variable Coefficient
Lower 
95% CI
Upper 
95% CI P value
Intercept 31 755.5 30 208.3 33 302.8 <0.001
Preintervention 
slope
496.3 444.8 547.8 <0.001
Level change 3023.4 −2151.5 8198.2 0.248
Postintervention 
slope
1379.7 904.4 1855.1 <0.001
NMIPs, non- medical independent prescribers.
Figure 2 Observed and predicted dispensed prescriptions 
in primary care by NMIPs prior to and following the 
implementation of primary care clusters in October 2015 (all 
Wales). NMIPs, non- medical independent prescriber.
Figure 1 Trend of the total number of items per 100 000 
population prescribed by all prescribers in primary care in 
Wales and dispensed in community pharmacies by year.
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DISCUSSION
Statement of the principal findings
This study investigated the number and associated 
prescribing volume of NMIPs before and after the imple-
mentation of primary care clusters in Wales. The number 
of NMIPs has increased in primary care in Wales over 
the study period and the majority of them were nurses, 
followed by pharmacists and physiotherapists. Inter-
estingly, the database did not identify other healthcare 
professionals who have prescribing authorisation in 
Wales, including therapeutic radiographers, chiropodists 
and podiatrists, and optometrists.16
The analysis of the prescribed number of items by 
NMIPs before and after the implementation of primary 
care clusters showed a 60% relative increase following 
the implementation of the primary care clusters in Wales. 
However, the prescribing of items by NMIPs was inconsis-
tent across the seven HBs.
Strengths and weaknesses
This is the first study that has used a secondary database 
analysis, which has provided insights and empirical find-
ings on the prescribing pattern of medicines by NMIPs 
over time in primary care in Wales. Although this study 
has achieved its aim and objectives, it has a number of 
limitations. First, the data provided via the CASPA software 
system was limited to the last 7 years. Second, this system 
was designed for financial reimbursement purposes for 
Figure 3 The total number of NMIPs (pharmacists, nurses 
and physiotherapists) who prescribed at least one item from 
April 2011 to March 2018 in primary care in Wales in different 
HBs. ABMUHB, Abertawe Bro Morgannwg University HB; 
ABUHB, Aneurin Bevan University HB; BCUHB, Betsi 
Cadwaladr University HB; CTMUHB, Cwm Taf Morgannwg 
University HB; CVUHB, Cardiff and Vale University HB; HB, 
health board; HDUHB, Hywel Dda University HB; NMIPs, 
non- medical independent prescribers; PTHB, Powys 
Teaching HB.
Table 2 Total number of items prescribed by NMIPs, as well as the number per 100 000 population and percentage of all 
items prescribed, per Hb in primary care in Wales and dispensed in community pharmacies since April 2011 until March 2018
Health board
Total number of items 
prescribed by NMIPs
% of the prescribed items by 
NMIPs in each HB*
Prescribed items by NMIPs per 100 000 
population
BCUHB 1 711 949 33.64 240 742.5
ABUHB 834 879 16.41 139 396.5
CVUHB 711 805 13.99 145 069.9
HDUHB 686 166 13.48 172 782.9
ABMUHB 573 624 11.27 106 813.2
CTMUHB 371 315 7.30 122 620.2
PTHB 198 667 3.91 137 000.6
*The percentage of the prescribed items by NMIPs in each HB was calculated based on the total number of items prescribed by NMIPs 
in all Wales.
ABMUHB, Abertawe Bro Morgannwg University HB; ABUHB, Aneurin Bevan University HB; BCUHB, Betsi Cadwaladr University 
HB; CTMUHB, Cwm Taf Morgannwg University HB; CVUHB, Cardiff and Vale University HB; HB, health board; HDUHB, Hywel Dda 
University HB; NMIPs, non- medical independent prescribers; PTHB, Powys Teaching HB.
Figure 4 Trend of the total number of dispensed items per 
100 000 population prescribed by NMIPs in primary care by 
health board (dashed line denotes introduction of primary 
care clusters in October 2015). HB, health board; NMIPs, 
non- medical independent prescribers; UHB, university health 
board.
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community pharmacies, which means that holding inves-
tigations at the level of patients or prescribers, such as 
stopping or changing patients’ medications, as well as 
clinical safety issues or other prescribing activities, were 
not possible. In addition, this system only captured NHS 
prescriptions that were dispensed in community pharma-
cies. Therefore, prescriptions issued by those prescribers 
that have not been dispensed as well as private prescrip-
tions that have been prescribed by NMIPs, such as optom-
etrists, were not captured by the system. Finally, the 
professions of NMIPs as pharmacist, nurse, physiother-
apist or other were not identified on the prescriptions 
and, consequently, in the CASPA system. The ITS anal-
ysis may have the limitation of the presence of unknown 
confounding variables, which are outside of the research-
er’s control, that may have happened at the same time 
of the intervention, and this leads to the difficulty of 
establishing causal effects.30 However, this analysis has 
the strength of evaluating data at the whole population 
level,31 which allowed the researchers to evaluate the util-
isation of NMIPs in primary care across all of Wales.
Comparison with other studies
The increase in the number of NMIPs in primary care 
in Wales may suggest that the primary care sector has 
recognised the skills of these practitioners, improving 
the skill- mix in this sector, and hopefully reducing the 
pressure on GPs, that is, the benefits described in the 
second Crown Report.32 Since the last quarter of 2015, 
the increase in the percentage of pharmacist IPs was 
higher than the increase in the percentage of nurse IPs 
(325% vs 108%). This could be explained by the imple-
mentation of the Welsh Government Plan,17 introduc-
tion of primary care clusters19 and the shortage of GPs in 
Wales, particularly in BCUHB.15 32–34 All of these factors 
may have contributed to recruitment of more pharmacist 
IPs.17 Pharmacist independent prescribing is a new role 
for pharmacists within clusters, with many secondary care 
based pharmacist IPs moving into these positions.21 This 
may lead to a shortage of pharmacists within secondary 
care and has highlighted the need for a pharmacy work-
force plan for Wales.
Although the number of nurse IPs is much greater than 
pharmacist IPs, they only represent 5% of the nursing 
workforce,35 while pharmacist IPs represent 7% of the 
pharmacist profession.36 The fact that there are more 
nurse IPs than other professions is in line with the find-
ings of other studies that have investigated the implemen-
tation of non- medical prescribing in England33 37 and 
Wales.16 Therapeutic radiographer IPs are based within 
secondary or tertiary care settings in Wales and therefore, 
they would be unlikely to be included in the database. 
However, the other professions, such as chiropodists, 
podiatrists and optometrists, could potentially be working 
in primary care settings but do not appear to have issued 
NHS prescriptions as they could have been prescribing 
medications for their patients within private hospitals, at 
point of care or not using their prescribing qualification. 
If they were not using their prescribing qualification, this 
may suggest that HBs need to investigate the reasons for 
that in order to prevent wasting the time and expenses 
incurred for training and failure to deliver an improved 
service to patients.
The increase in the number of NMIPs, particu-
larly pharmacist IPs, may explain the increased rate of 
prescribing of medicines by these practitioners over the 
same period. The high number of prescribed items by 
NMIPs in BCUHB (34%) compared with other HBs could 
be explained by the high number of NMIPs in BCUHB 
(246 NMIPs). It is evident that the utilisation of NMIPs is 
inconsistent across the seven HBs in Wales, which supports 
previous research.16 BCUHB and HDUHB represent the 
largest geographical areas in Wales compared with other 
HBs38 but have the lowest number of GPs per 10 000 
population (6.1 and 5.8, respectively).39 The low number 
of GPs in these HBs could be related to issues of recruit-
ment, as well as the difficulty in keeping those who are 
already employed in their positions.34 40 The shortage 
of GPs in these HBs may explain the early adoption of 
non- medical independent prescribing. Although PTHB 
showed the lowest number of items prescribed by NMIPs 
over the study period, it is the smallest geographical area 
in Wales with the lowest population compared with other 
HBs. An equivalent increase in the number of prescribers 
and items would therefore produce a bigger percentage 
change than in a larger HB. However, the large increase 
in the trend of the prescribing items in this HB over the 
last 2 years of the study period may be explained by the 
increase in the number of NMIPs. Moreover, PTHB only 
has primary care services, so while other HBs may have 
been training IPs in both primary and secondary care 
settings, the focus in PTHB would have been primary 
Figure 5 Trend of the total number of dispensed items per 
100 000 population prescribed by NMIPs in primary care by 
health board (dashed line denotes introduction of primary 
care clusters in October 2015). *Final seven outlying data 
points in Powys Teaching Health Board removed to illustrate 
trends in other health boards. HB, health board; NMIPs, 
non- medical independent prescribers; UHB, university health 
board.
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care only, which may have resulted in a greater change. 
However, due to the nature of the database used, it was 
not possible to investigate this further, and this could be 
the focus of future work.
The meaning of the study: possible explanations and 
implications for clinicians and policy makers
The findings of this study showed inconsistency in terms 
of the implementation of the NMIPs’ services between 
HBs in primary care in Wales, particularly after the 
primary care clusters’ implementation. Although there 
is a lack of evidence with regards to the reasons and 
barriers behind this, some reasons that may have contrib-
uted to lower utilisation of this service in some HBs may 
include the lack of funding16 37 41 42 and lack of a plan or 
strategy to develop this service.37 However, these studies 
are outdated given the pace of change. Moreover, it has 
not been conducted in Wales in particular, which may 
not reflect recent practice and policies in this country. 
Due to the lack of evidence regarding the impact of these 
barriers on the implementation of non- medical indepen-
dent prescribing in each HB, further research is required 
to investigate this matter. This study provides the initial 
evidence for such research, as well as providing the 
opportunity to share learning among HBs.
Unanswered questions and future studies
This study provides a research agenda for further investi-
gation to examine questions related to efficiency, quality 
of prescribing, cost- effectiveness and improved access to 
services provided by NMIPs. With the presence of some 
variety and inconsistency in the prescribing trend of 
NMIPs across different HBs, this provides an opportunity 
to share the knowledge on advanced and novel services 
provided by these prescribers as well as to investigate the 
reasons behind it.
CONCLUSION
The number of NMIPs and their prescribing trends of 
medicines increased in Wales in general, as well as in the 
majority of HBs, particularly the number of pharmacist 
IPs, since the implementation of primary care clusters. 
This could be related to the implementation of the Welsh 
Government Plan17 and the introduction of primary care 
clusters. The findings of this study may suggest that the 
increased number of NMIPs in the primary care sector 
in Wales over time may help to reduce the pressure on 
GPs and improve the skill- mix across different thera-
peutic areas. This aligns with the main reasons for the 
implementation of non- medical prescribing in the UK, 
as outlined in the second Crown Report.32 Future studies 
should focus on efficiency and quality of prescribing by 
NMIPs in primary care.
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